Compare R & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | R | CRL |
|---|---|---|
| Founded | 1933 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 10.8B |
| IPO Year | 1994 | 1999 |
| Metric | R | CRL |
|---|---|---|
| Price | $247.99 | $291.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $238.56 | $198.27 |
| AVG Volume (30 Days) | 303.7K | ★ 884.8K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | ★ 7.96 | N/A |
| EPS | ★ 5.71 | N/A |
| Revenue | ★ $12,665,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $5.00 | N/A |
| Revenue Next Year | $5.05 | $3.04 |
| P/E Ratio | $43.88 | ★ N/A |
| Revenue Growth | 0.23 | ★ 10.48 |
| 52 Week Low | $157.77 | $144.26 |
| 52 Week High | $284.25 | $294.56 |
| Indicator | R | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 34.13 | 76.01 |
| Support Level | $206.69 | $149.72 |
| Resistance Level | $259.00 | N/A |
| Average True Range (ATR) | 5.71 | 10.63 |
| MACD | -1.44 | 1.86 |
| Stochastic Oscillator | 4.84 | 93.41 |
Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.